{"id":"https://openalex.org/W2168762880","doi":null,"title":"Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide.","display_name":"Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide.","publication_year":2000,"publication_date":"2000-02-01","ids":{"openalex":"https://openalex.org/W2168762880","mag":"2168762880","pmid":"https://pubmed.ncbi.nlm.nih.gov/10690516"},"language":"en","primary_location":{"id":"pmid:10690516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10690516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I2801120601","display_name":"Western Infirmary","ror":"https://ror.org/02e22bh87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2801120601"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J S de Bono","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Beatson Oncology Centre, Western Infirmary, Glasgow, United Kingdom. gpmv08@udcf.gla.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Beatson Oncology Centre, Western Infirmary, Glasgow, United Kingdom. gpmv08@udcf.gla.ac.uk","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I2801120601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067606220","display_name":"Angus George Dalgleish","orcid":"https://orcid.org/0000-0003-3511-3059","observed_orcids":["https://orcid.org/0000-0003-3511-3059"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A G Dalgleish","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080571689","display_name":"J Carmichael","orcid":"https://orcid.org/0009-0004-8793-8823","observed_orcids":["https://orcid.org/0009-0004-8793-8823"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Carmichael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J Diffley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Diffley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085230100","display_name":"Fiona J. Lofts","orcid":"https://orcid.org/0000-0002-6268-6015","observed_orcids":["https://orcid.org/0000-0002-6268-6015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F J Lofts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067539526","display_name":"D. Fyffe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Fyffe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084653587","display_name":"Sian Ellard","orcid":"https://orcid.org/0000-0002-7620-5526","observed_orcids":["https://orcid.org/0000-0002-7620-5526"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Ellard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090180943","display_name":"R J Gordon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R J Gordon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112210773","display_name":"C. J. Brindley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J Brindley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109354205","display_name":"T. R. J. Evans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T R Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8251,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.72423821,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":"2","first_page":"397","last_page":"405"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-a-analogues","display_name":"lipid A analogues","score":0.902999997138977},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9570000171661377},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8899999856948853},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.953000009059906},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.8560000061988831},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.9309999942779541},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7289999723434448},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.859000027179718},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.824999988079071},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6480000019073486},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.677534818649292},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6229639053344727},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4993472099304199},{"id":"https://openalex.org/C2778616394","wikidata":"https://www.wikidata.org/wiki/Q474959","display_name":"myalgia","level":2,"score":0.48597490787506104},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4815669059753418},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.44330456852912903},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4345170855522156},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.41394349932670593},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4006991982460022},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37701526284217834}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10690516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10690516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2168762880","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10690516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W54091601","https://openalex.org/W1484121218","https://openalex.org/W1605016454","https://openalex.org/W1967115584","https://openalex.org/W1994051663","https://openalex.org/W1998954554","https://openalex.org/W2009707869","https://openalex.org/W2009908333","https://openalex.org/W2026924138","https://openalex.org/W2032703806","https://openalex.org/W2052920262","https://openalex.org/W2056328872","https://openalex.org/W2125237590","https://openalex.org/W2133556184","https://openalex.org/W2134520434","https://openalex.org/W2143710143","https://openalex.org/W2151957470","https://openalex.org/W2318588165","https://openalex.org/W2336213711","https://openalex.org/W2400142713","https://openalex.org/W2413018738","https://openalex.org/W2439239394","https://openalex.org/W2469937525"],"related_works":["https://openalex.org/W1994168462","https://openalex.org/W3034387514","https://openalex.org/W2027782959","https://openalex.org/W2086921032","https://openalex.org/W1998954554","https://openalex.org/W2416665340","https://openalex.org/W1901907570","https://openalex.org/W4406070406","https://openalex.org/W2046201420","https://openalex.org/W1967384736"],"abstract_inverted_index":{"ONO-4007":[0,44,58,193,207,234],"is":[1],"a":[2,74,86,101,114,209,217,225,240],"synthetic":[3],"analogue":[4],"of":[5,10,20,28,34,91,104,108,116,152,192,198,220,228,233,246,280,292],"the":[6,18,26,32,96,168,171,276,281,289],"lipid":[7],"A":[8],"moiety":[9],"bacterial":[11],"lipopolysaccharide,":[12],"which":[13],"exhibits":[14],"antitumor":[15,255,290],"activity":[16,291],"by":[17,43,85,100],"induction":[19,42],"intratumoral":[21],"tumor":[22,247],"necrosis":[23,248],"factor":[24,249],"alpha,":[25,38],"potentiation":[27],"tumor-infiltrating":[29],"macrophages,":[30],"and":[31,40,53,66,126,188,200,216,251],"inhibition":[33],"angiogenesis.":[35],"Interleukin":[36],"(IL)-1":[37],"IL-6,":[39],"IL-12":[41],"activates":[45],"cytotoxic":[46],"natural":[47],"killer":[48],"cells":[49],"to":[50,61,113,195,205,237,287],"up-regulate":[51],"IFN-gamma":[52],"nitric":[54],"oxide":[55],"synthase":[56],"activity.":[57],"was":[59,133,235],"given":[60],"24":[62],"patients":[63,110,154,162,260,271],"(13":[64],"males":[65],"11":[67],"females;":[68],"median":[69],"age,":[70],"53":[71],"years)":[72],"as":[73],"30-min":[75],"i.v.":[76],"infusion":[77],"on":[78,82],"day":[79,83],"1,":[80],"followed":[81,99],"15":[84],"first":[87],"treatment":[88,118],"cycle":[89],"consisting":[90],"three":[92],"weekly":[93],"infusions":[94],"at":[95,120,155,165,265],"same":[97],"dose,":[98],"rest":[102],"period":[103],"1":[105],"week.":[106],"Cohorts":[107],"six":[109,153,161],"received":[111],"up":[112],"maximum":[115,130,172],"four":[117],"cycles":[119],"increasing":[121],"dose":[122,132,157,169,199],"levels":[123,245],"(75,":[124],"100,":[125],"125":[127,134],"mg).":[128],"The":[129,190,231],"tolerated":[131,173],"mg,":[135,167],"with":[136,147,203,224],"grade":[137,178],"3":[138],"National":[139,180],"Cancer":[140,181],"Institute":[141,182],"Common":[142,183],"Toxicity":[143,184],"Criteria":[144,185],"toxicity":[145],"(rigors":[146],"cyanosis)":[148],"occurring":[149],"in":[150,239,243],"two":[151,267],"this":[156],"level.":[158],"An":[159],"additional":[160],"were":[163,257],"treated":[164],"100":[166],"below":[170],"dose.":[174],"Other":[175],"toxicities":[176],"included":[177],"2":[179],"myalgia,":[186],"nausea,":[187],"hypotension.":[189],"pharmacokinetics":[191],"appeared":[194],"be":[196],"independent":[197],"showed":[201],"linearity":[202],"respect":[204],"time.":[206],"has":[208],"low":[210],"systemic":[211],"clearance":[212],"(approximately":[213],"1.3":[214],"ml/min)":[215],"small":[218],"volume":[219],"distribution":[221],"(5-8":[222],"liters)":[223],"long":[226],"t1/2":[227],"74-95":[229],"h.":[230],"administration":[232],"shown":[236],"result":[238],"significant":[241],"increase":[242],"circulating":[244],"alpha":[250],"IL-6.":[252],"No":[253],"objective":[254],"responses":[256],"observed.":[258],"Seven":[259],"maintained":[261,272],"stable":[262,273],"disease":[263,274],"for":[264,275],"least":[266],"cycles,":[268],"whereas":[269],"five":[270],"full":[277],"four-cycle":[278],"duration":[279],"study.":[282],"Additional":[283],"studies":[284],"are":[285],"required":[286],"determine":[288],"ONO-4007.":[293]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}